Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

The association between weight change and symptom reduction in the CATIE schizophrenia trial.

Hermes E, Nasrallah H, Davis V, Meyer J, McEvoy J, Goff D, Davis S, Stroup TS, Swartz M, Lieberman J, Rosenheck R.

Schizophr Res. 2011 May;128(1-3):166-70. doi: 10.1016/j.schres.2011.01.022. Epub 2011 Feb 21.

2.

Cardiovascular risk in a first-episode psychosis sample: a 'critical period' for prevention?

Phutane VH, Tek C, Chwastiak L, Ratliff JC, Ozyuksel B, Woods SW, Srihari VH.

Schizophr Res. 2011 Apr;127(1-3):257-61. doi: 10.1016/j.schres.2010.12.008. Epub 2011 Jan 15.

3.

From the Cover: Antipsychotic drug-induced weight gain mediated by histamine H1 receptor-linked activation of hypothalamic AMP-kinase.

Kim SF, Huang AS, Snowman AM, Teuscher C, Snyder SH.

Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3456-9. Epub 2007 Feb 20.

4.
5.

Metabolic Issues With Atypical Antipsychotics in Primary Care: Dispelling the Myths.

Kabinoff GS, Toalson PA, Healey KM, McGuire HC, Hay DP.

Prim Care Companion J Clin Psychiatry. 2003 Feb;5(1):6-14.

Supplemental Content

Support Center